Ikarian Capital’s Incyte INCY Stock Holding History

Ikarian Capital’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100,000	Closed	-$8.97M	–	246
2020 Q3	$8.97M	Buy	+100,000	New	+$9.65M	0.65%	40

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ikarian Capital's INCY Position: Q4 2021 in Review

Ikarian Capital sold out of Incyte (INCY) in Q4 2021, closing a stake of 32,666 shares — an estimated $2.25M sold.

Ikarian Capital first reported a position in INCY in Q2 2020 and held it in 4 quarters. The position peaked at $3.07M in Q2 2021. 525 funds tracked by Wall St. Rank hold INCY as of Q4 2021.

Ikarian Capital reported no remaining Incyte position as of Q4 2021 after selling out during the quarter.
Ikarian Capital sold 32,666 Incyte shares in Q4 2021, an estimated $2.25M.
Ikarian Capital first reported a position in Incyte in Q2 2020 and held it in 4 quarters.
Ikarian Capital's Incyte position peaked at $3.07M in Q2 2021.
525 funds tracked by Wall St. Rank held Incyte as of Q4 2021.

Based on Ikarian Capital's 13F filing for Q4 2021, filed 14 Feb 2022.